Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

68 trials with published results (13%)

Research Maturity

303 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.1%

38 terminated out of 539 trials

Success Rate

88.9%

+2.3% vs benchmark

Late-Stage Pipeline

18%

98 trials in Phase 3/4

Results Transparency

22%

68 of 303 completed with results

Key Signals

68 with results89% success38 terminated

Data Visualizations

Phase Distribution

293Total
Not Applicable (155)
Early P 1 (7)
P 1 (14)
P 2 (19)
P 3 (44)
P 4 (54)

Trial Status

Completed303
Unknown90
Recruiting55
Terminated38
Withdrawn21
Active Not Recruiting20

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 303 completed trials

Clinical Trials (539)

Showing 20 of 20 trials
NCT07728448Not Yet RecruitingPrimary

Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening Symptoms

NCT07350499Recruiting

Aspiration Thrombectomy Using the Symphony or Prodigy System

NCT00005152Active Not Recruiting

Nurses' Health Study (Cardiovascular Component)

NCT06041594Not ApplicableRecruitingPrimary

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

NCT06015529Not ApplicableCompletedPrimary

Diagnostic Strategy for Suspected Pulmonary Embolism Based on 4PEPS

NCT04014972Completed

Current Status and Determinants of Care for Patients With Acute Chest Pain in China: A Retrospective Analysis of Data From the China Chest Pain Center Registry

NCT06055920Not ApplicableActive Not RecruitingPrimary

The PEERLESS II Study

NCT06433011Not ApplicableRecruitingPrimary

The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism

NCT07689136Completed

Timing of Thromboprophylaxis After Postpartum Hemorrhage

NCT06588634Not ApplicableRecruitingPrimary

The PERSEVERE Study

NCT06600542RecruitingPrimary

Inari VISION Registry

NCT06183944CompletedPrimary

Data Clustering Study With Artificial Intelligence and Phenotyping of Patients With Acute Pulmonary Embolism

NCT05413317CompletedPrimary

Contribution of Lower Limb Venous Colour Doppler Ultrasound in the Diagnosis of Pulmonary Embolism Recurrence

NCT04798261RecruitingPrimary

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

NCT06453876Phase 3RecruitingPrimary

Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)

NCT04430569Phase 3Active Not RecruitingPrimary

Pulmonary Embolism International THrOmbolysis Study-3

NCT05408546Phase 2Active Not RecruitingPrimary

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial

NCT04790370Phase 4Active Not RecruitingPrimary

Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism

NCT06195540Phase 3Recruiting

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

NCT07659106Not ApplicableNot Yet Recruiting

Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism

Scroll to load more

Research Network

Activity Timeline